TORRENT FDA Approval ANDA 203969

ANDA 203969

TORRENT

FDA Drug Application

Application #203969

Application Sponsors

ANDA 203969TORRENT

Marketing Status

Prescription001
Prescription002
Prescription003

Application Products

001TABLET, EXTENDED RELEASE;ORAL100MG0BUPROPION HYDROCHLORIDEBUPROPION HYDROCHLORIDE
002TABLET, EXTENDED RELEASE;ORAL150MG0BUPROPION HYDROCHLORIDEBUPROPION HYDROCHLORIDE
003TABLET, EXTENDED RELEASE;ORAL200MG0BUPROPION HYDROCHLORIDEBUPROPION HYDROCHLORIDE

FDA Submissions

UNKNOWN; ORIG1AP2014-10-31
LABELING; LabelingSUPPL2AP2021-03-01STANDARD
LABELING; LabelingSUPPL4AP2021-03-01STANDARD

Submissions Property Types

ORIG1Null19
SUPPL2Null7
SUPPL4Null15

TE Codes

001PrescriptionAB1
002PrescriptionAB1
003PrescriptionAB1

CDER Filings

TORRENT
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 203969
            [companyName] => TORRENT
            [docInserts] => ["",""]
            [products] => [{"drugName":"BUPROPION HYDROCHLORIDE","activeIngredients":"BUPROPION HYDROCHLORIDE","strength":"100MG","dosageForm":"TABLET, EXTENDED RELEASE;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"BUPROPION HYDROCHLORIDE","activeIngredients":"BUPROPION HYDROCHLORIDE","strength":"150MG","dosageForm":"TABLET, EXTENDED RELEASE;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"BUPROPION HYDROCHLORIDE","activeIngredients":"BUPROPION HYDROCHLORIDE","strength":"200MG","dosageForm":"TABLET, EXTENDED RELEASE;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"10\/31\/2014","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2014-10-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.